GZMK+CD8+ T cells target a specific acinar cell type in Sjögren's disease

Using single-cell and spatial transcriptomics and proteomics, this study identifies a selective loss of PRR4⁺CST3⁺WFDC2⁻ seromucous acinar cells and a rise in GZMK⁺CD8⁺ T cells in Sjögren's disease, revealing distinct immune-mediated epithelial remodeling and interferon-driven dysfunction across diverse clinical presentations. These findings uncover a novel sub-cytolytic effector mechanism by which GZMK⁺CD8⁺ T cells impair mitochondrial integrity and activate innate immune signaling, linking epithelial injury to type I interferon responses and offering new therapeutic targets.

Authors

Institutions

Publication Details

Journal
Annals of the Rheumatic Diseases
Published
2025-10-01
DOI
https://doi.org/10.1016/j.ard.2025.08.014
Citations
5
Primary Topic
Salivary Gland Disorders and Functions
Type
article
Field-Weighted Citation Impact
5.82

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

GZMK+CD8+ T cells target a specific acinar cell type in Sjögren's disease

Sarthak Gupta, Quinn T. Easter, Mehdi Abed, Marit H. Aure et al.
5 citations
Annals of the Rheumatic Diseases
Salivary Gland Disorders and Functions
5.82
article

GZMK+CD8+ T cells target a specific acinar cell type in Sjögren's disease

Sarthak Gupta, Quinn T. Easter, Mehdi Abed, Marit H. Aure, Robert J. Morell, Thomas Pranzatelli, Alan N. Baer, Daniel Martı́n, David E. Kleiner, Philip L. Johnson, Anson T. Ku, Sarah Amalia Teichmann, Katarzyna M. Tyc, Zara Ahmed, Paola Pérez, Adam G. Sowalsky, Peter D. Burbelo, Ross Lake, M Dezfulian, Xufeng Qu, Blake M. Warner, Amanda J. Oliver, Khoa Huynh, M. Teresa Magone, A. Darise Farris, John A. Chiorini, Daniel L. Barber, Lam C. Tsoi, Johann Eli Gudjonsson, Kevin M. Byrd, Nicholas Rachmaninoff, Christopher J. Lessard, Eiko Yamada, Eileen Pelayo, Zohreh Khavandgar, Bruno Fernandes Matuck, Kalie Dominick, Jose Maldonado-Ortiz, Rachael Bogle, Shunsuke Sakai, Jinze Liu, Changyu Zheng, Shyh-Ing Jang
article en
5 citations

Abstract

Using single-cell and spatial transcriptomics and proteomics, this study identifies a selective loss of PRR4⁺CST3⁺WFDC2⁻ seromucous acinar cells and a rise in GZMK⁺CD8⁺ T cells in Sjögren's disease, revealing distinct immune-mediated epithelial remodeling and interferon-driven dysfunction across diverse clinical presentations. These findings uncover a novel sub-cytolytic effector mechanism by which GZMK⁺CD8⁺ T cells impair mitochondrial integrity and activate innate immune signaling, linking epithelial injury to type I interferon responses and offering new therapeutic targets.

Annals of the Rheumatic Diseases
National Institutes of Health (US), Harvard University (US), Virginia Commonwealth University (US), Wellcome/MRC Cambridge Stem Cell Institute (GB), Wellcome Sanger Institute (GB), Oklahoma Medical Research Foundation (US), National Institute of Arthritis and Musculoskeletal and Skin Diseases (US), National Institute of Dental and Craniofacial Research (US), Michigan Medicine (US), National Institute of Allergy and Infectious Diseases (US), National Eye Institute (US), National Cancer Institute (US), Institut de Recherche et d’Innovation (FR), Center for Cancer Research (US), National Institute on Deafness and Other Communication Disorders (US), University of Maryland, College Park (US)
National Institutes of Health, National Cancer Institute, National Institute of Dental and Craniofacial Research
Openalex Percentile: Top 4%
Salivary Gland Disorders and Functions
5.82
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.